Company intelligence / Profile preview

Tianyin Pharmaceutical

Chengdu, Sichuan, Chinatianyinpharma.com ↗

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Tianyin Pharmaceutical has a broad portfolio with over 50 approved medicines—mainly modernized TCMs and generics—many included on China’s National Medical Reimbursement List and Essential Drug List. The company maintains GMP-certified manufacturing facilities and collaborates with leading academic institutions for R&D. Recent clinical results include approvals for new generic drugs such as Pediatric Fever and Cough Oral Liquid and Antibacterial/Anti-inflammatory Capsules.

Therapeutic areas: Men's HealthPulmonologyInfectious DiseasesOtherRheumatologyGastroenterologyCardiovascularOphthalmologyNeurologyWomen's Health
Modalities: Small moleculeHerbal medicineTraditional Chinese Medicine (TCM)
Industry: Biotech

Drug pipeline

1 asset

Yinxingmihuan

Unknown

Partnerships

Joint venture with Buchang Pharma reported in 2015

Beyond the preview

Go deeper on Tianyin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianyin Pharmaceutical.